(Q97434210)
Statements
2 references
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use (English)
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use (English)
Carsten Tschöpe
2 references
Dimitrios Farmakis
2 references
Zoltán Papp
2 references
Piergiuseppe Agostoni
2 references
Julian Alvarez
2 references
Dominique Bettex
2 references
Stefan Bouchez
2 references
Vladimir Cˇerný
Josep Comin-Colet
2 references
Marisa G Crespo-Leiro
2 references
Juan F Delgado
2 references
Istvan Édes
Alexander A Eremenko
2 references
Francesco Fedele
2 references
Cândida Fonseca
2 references
Sonja Fruhwald
2 references
Fabio Guarracino
2 references
Veli-Pekka Harjola
2 references
Matthias Heringlake
2 references
Antoine Herpain
2 references
Leo Ma Heunks
Tryggve Husebye
2 references
Višnja Ivancan
2 references
Kristjan Karason
2 references
Sundeep Kaul
2 references
Matti Kivikko
2 references
Janek Kubica
2 references
Josep Masip
2 references
Markku S Nieminen
2 references
Fabrizio Oliva
2 references
Julius-Gyula Papp
John Parissis
2 references
Alexander Parkhomenko
2 references
Pentti Põder
2 references
Gerhard Pölzl
2 references
Alexander Reinecke
2 references
Sven-Erik Ricksten
2 references
Hynek Riha
2 references
Alain Rudiger
2 references
Toni Sarapohja
2 references
Robert Hg Schwinger
Wolfgang Toller
2 references
Gerhard Wikström
2 references
Dirk von Lewinski
2 references
Bojan Vrtovec
2 references
Vladimir Černý
István Édes
Leo M A Heunks
Julius G Papp
Robert H G Schwinger
22 June 2020
1 July 2020
3 references
27 August 2022
Identifiers
2 references
2 references